Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001267602-23-000027
Filing Date
2023-03-31
Accepted
2023-03-31 16:08:47
Documents
101
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K alim-20221231x10k.htm   iXBRL 10-K 4449644
2 EX-10.12 alim-20221231xex10_12.htm EX-10.12 219430
3 EX-21.1 alim-20221231xex21_1.htm EX-21.1 6242
4 EX-23.1 alim-20221231xex23_1.htm EX-23.1 3822
5 EX-31.1 alim-20221231xex31_1.htm EX-31.1 20840
6 EX-31.2 alim-20221231xex31_2.htm EX-31.2 20989
7 EX-32.1 alim-20221231xex32_1.htm EX-32.1 18162
  Complete submission text file 0001267602-23-000027.txt   16491838

Data Files

Seq Description Document Type Size
8 EX-101.SCH alim-20221231.xsd EX-101.SCH 78813
9 EX-101.CAL alim-20221231_cal.xml EX-101.CAL 87843
10 EX-101.DEF alim-20221231_def.xml EX-101.DEF 326383
11 EX-101.LAB alim-20221231_lab.xml EX-101.LAB 774695
12 EX-101.PRE alim-20221231_pre.xml EX-101.PRE 595987
95 EXTRACTED XBRL INSTANCE DOCUMENT alim-20221231x10k_htm.xml XML 3488594
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

EIN.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34703 | Film No.: 23787667
SIC: 2834 Pharmaceutical Preparations